
Sally Hodder, MD, discusses the most clinically relevant data on metabolic complications and adverse events from the 2007 International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe data on the prevention of antiretroviral-associated hypersensitivity reactions
- Specify data on metabolic complications observed in recent studies of approved and investigational antiretroviral agents
- Discuss recent insights into the management and prevention of metabolic complications in HIV-infected patients